Search

Search Results
Results 4691 - 4700 of 4717 for Targeted drug delivery
  • Identifying hidden contaminants in nucleic acid samples
    White Paper - 30 Apr 2026
    Chemometric algorithms and spectral libraries analyze subtle spectrum changes to predict contaminants in samples.
  • Comprehensive analysis of sulfotransferase activity using LC-MS/MS
    Health - 9 Jan 2026
    Explore how LC-MS/MS enables high-throughput phenotyping and inhibition profiling of sulfotransferase enzymes.
  • Scintica Instrumentation Inc.
    Supplier - 23 Jul 2021
    Scintica Instrumentation Inc., a high value distributor of scientific medical equipment, was created as a joint venture between two companies, Indus Instruments and ONS Projects Inc., both with long...
  • Hanson Wade Group - 7th CNS Drug Delivery Summit
    Supplier - 10 Nov 2025
    Welcome to the 7th CNS Drug Delivery Summit
  • GenScript
    Supplier - 13 Nov 2018
    Genscript is the world’s leading biotech company providing life sciences services and products. With gene synthesis, peptide, protein, antibody and preclinical drug development service capabilities,...
  • Targeting Protein Misfolding Congress 2021
    Supplier - 7 Dec 2020
    With the neurological drug market now worth $86 billion, and the FDA set to reach a decision on Biogen’s Acudanimib in Spring, whether you’re focused on oncology, Alzheimer’s or ALS, it’s an exciting...
  • Exom BioPharma, Inc.
    Supplier - 6 Sep 2024
    Exom BioPharma offers high quality research kits for exosome isolation and analysis, manufacturing highly purified exosomes from various cell lines, and animal and plant sources for research and...
  • B. Braun Melsungen AG
    Supplier - 30 Nov 2012
    B. Braun is one of the world's leading providers and manufacturers of healthcare solutions today. Every service that B. Braun provides incorporates the entirety of our knowledge and skills, the...
  • Blood-Brain Barrier Delivery Summit (B3DD)
    Supplier - 17 Jun 2019
    B3DD is a conference dedicated to addressing the translational challenges of effective and safe delivery of CNS drug candidates that cross the blood-brain barrier.
  • Ubiquigent Limited
    Supplier - 23 Jan 2023
    As pioneers in the rapidly emerging deubiquitinase (DUB) space, Ubiquigent™ is uniquely positioned to drive forward the discovery and development of novel DUB modulators as powerful new therapeutics...

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback